Skip to content

Multicenter Trial on the Ultrasound Diagnostic Criteria of Cervical Lymph Node Metastasis from Head and Neck Cancer

Multicenter Trial on the Ultrasound Diagnostic Criteria of Cervical Lymph Node Metastasis from Head and Neck Cancer - Clinical Study on Ultrasound of Cervical Lymph Node Metastasis (USNLY Study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020217
Enrollment
106
Registered
2015-12-17
Start date
2015-09-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

None listed

Sponsors

Kanagawa Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with head and neck cancer who are planning cervical lymph node dissection 2) Patients who are evaluated for cervical lymph node with ultrasonography 3) Patients who are evaluated for cervical lymph node metastasis pathologically as well as macrographically after the surgery 4) Patients who give written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with relapsed head and neck cancer previously treated by cervical dissection

Design outcomes

Primary

MeasureTime frame
Accuracy when using the revised diagnostic criteria of ultrasonography for cervical lymph node metastasis from head and neck cancer

Secondary

MeasureTime frame
Exploratory outcomes on variables to predict the accuracy of diagnostic criteria and the difference in the accuracy between institutes

Countries

Japan

Contacts

Public ContactMadoka Furukawa, MD

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization Department of Head and Neck Surgery

furukawam@kcch.jp045-520-2222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026